Announcements Trials
Browse Landscape

Phase

Phase 2 71Phase NA 59Phase 1 54Phase 1/2 25Phase EARLY_PHASE1 14Phase 3 8Phase 4 4Phase 2/3 2

Status

Completed 14Unknown 10Recruiting 8Terminated 6Not yet recruiting 4Active not recruiting 4Withdrawn 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 15Head & Neck 5Breast 4Other hematologic neoplasm 3Lymphoid 3Genitourinary 3Dermatologic 3Sarcoma 2Gynecologic 2CNS 2Thoracic 1Other neoplasm 1Myeloid 1

Conditions

Glioblastoma 2Recurrence 1Oligodendroglioma 1Glioma 1Astrocytoma 1

Interventions

vocimagene amiretrorepvec 1carbon-11 acetate 1Temozolomide 1Radiotherapy 1Radiation 1Magnetic Resonance Spectroscopy 1DNA 1Carbon-11 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Withdrawn × CNS × Clear all
NCT04105374 2026-05-07

Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma

NRG Oncology

Phase 2/3 Withdrawn
CNS

Astrocytoma, Glioblastoma, Oligodendroglioma

NCT01961934 2016-09-28

C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression

Phoenix Molecular Imaging

Phase 2/3 Withdrawn
CNS

Glioblastoma, Glioma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡